Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery

Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery

Abstract Background Colorectal peritoneal metastases (CRPM) affects 15% of patients at initial colorectal cancer diagnosis. Neoadjuvant chemotherapy (NAC) prior to cytoreductive surgery (CRS) has been demonstrated to be a safe and feasible option, however there is limited data describing its efficac...

Full description

Bibliographic Details
Main Authors: Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, Shoma Barat, Winston Liauw, David L Morris
Format: Article
Language:English
Published: BMC 2024-04-01
Series:World Journal of Surgical Oncology
Subjects:
Colorectal cancer
Peritoneal metastases
Cytoreductive surgery
Neoadjuvant chemotherapy
HIPEC
Online Access:https://doi.org/10.1186/s12957-024-03392-8

Internet

https://doi.org/10.1186/s12957-024-03392-8

Similar Items